Colfosceril palmitate

Pharmaceutical drug

R07AA01 (WHO)

Identifiers

IUPAC name

2,3-di(hexadecanoyloxy)propyl 2-trimethylazaniumylethyl phosphate

CAS Number

63-89-8^Y

PubChem CID

6138

ChemSpider

5908^Y

UNII

319X2NFW0A

KEGG

D03585^Y

ChEMBL

ChEMBL1200737^N

CompTox Dashboard (EPA)

DTXSID5046720

ECHA InfoCard100.000.516

Chemical and physical dataFormulaC₄₀H₈₀NO₈PMolar mass734.053 g·mol⁻¹3D model (JSmol)

Interactive image

SMILES

O=C(OCC(OC(=O)CCCCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C)CCCCCCCCCCCCCCC

InChI

InChI=1S/C40H80NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-39(42)46-36-38(37-48-50(44,45)47-35-34-41(3,4)5)49-40(43)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h38H,6-37H2,1-5H3^Y
Key:KILNVBDSWZSGLL-UHFFFAOYSA-N^Y

^NY (what is this?) (verify)

Colfosceril palmitate (trade name Exosurf) is a drug used as a pulmonary surfactant.^[1] It is a drug that is used in surfactant deficient conditions such as infant respiratory distress syndrome in newborns.

References

^ Rubin BK (1996). "Therapeutic aerosols and airway secretions". Journal of Aerosol Medicine. 9 (1): 123–30. doi:10.1089/jam.1996.9.123. PMID 10160202.

Other respiratory system products (R07)

Lung surfactants